IP Verse

Microencapsulation Of Clomazone By Means Of A Refined Process And Specific Microcapsules Produced Thereof

PatentPatent Analysis

EP2487192

FMC
Application Number
EP10011557A
Filing Date
Mar 30, 2006
Status
Revoked
Jan 5, 2024
Grant Date
Mar 3, 2021
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3094631B2
EP3236954B2
EP4058652B1

Bibliography

The patent EP2487192B1 was granted to FMC on Mar 3, 2021 following the initial filing on Mar 30, 2006 under the application number EP10011557A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ROTAMDec 2, 2021ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents